Side by side

Compare peptides.

See why people discuss them, what the evidence supports, and where amount information comes from.

Choose two compounds

Add up to four if you need to. Evidence labels apply to specific claims and products.

Compare more (up to four)

Tissue & skin

KLOW 80 mg Research Blend

A 50/10/10/10 blend sold with TB-500 wording. Its batch report should be checked for the exact thymosin form.

Why people are interested

KLOW combines four talked-about ingredients, so it appears in skin, recovery, and inflammation conversations.

What the research supports

No controlled human outcome study of the specific 80 mg blend is established here. Ingredient-specific studies cannot prove the mixture's benefits or safety.

Clinical or label amounts

Evidence gap

No amount established for this research vial

Publicly reported amounts

Amount in one post: 8 mg total blend each time: 5 mg GHK-Cu and 1 mg each of three 10 mg ingredients by the stated 50/10/10/10 ratio

One checked post, not a typical amount or a recommendation.

Public reports and source limits →
Read the full KLOW 80 mg Research Blend profile and sources →
Metabolic & appetite

Tirzepatide

Tirzepatide acts on GIP and GLP-1 receptors. It has been studied in human medicine products for blood sugar and metabolic effects.

Why people are interested

Tirzepatide is well known because prescription versions are used for type 2 diabetes, chronic weight management, and certain sleep-apnea patients. JD-2TR is a seller code associated with tirzepatide in listed batch reports.

What the research supports

The strongest evidence belongs to manufactured prescription tirzepatide products studied in clinical trials. FDA approval applies to those products and specific indications, not automatically to a research-only JD-2TR vial.

Clinical or label amounts

Prescription product label

2.5–15 mg

Once weekly in adults

Specific to the named study or medicine, not this research vial.

Mounjaro prescribing information (2026) ↗

Publicly reported amounts

Amount in one post: 2.5 mg each time from a stated 10 mg dry vial

One checked post, not a typical amount or a recommendation.

Public reports and source limits →
Read the full Tirzepatide profile and sources →

FDA-approved uses belong to named prescription products and indications; they do not transfer to an online research vial. Human, animal, cell, and anecdotal evidence are different. How we check sources →